GPFT: AI 评分 45/100 — AI 分析 (4月 2026)

Grapefruit USA, Inc. is a manufacturer and distributor of cannabis products, primarily operating in California. The company focuses on its Hourglass time-release THC+CBD-infused topical cream, sold through its online store.

Key Facts: AI Score: 45/100 Sector: Healthcare

公司概况

概要：

Grapefruit USA, Inc., established in 2017, operates within the specialty cannabis market, focusing on the manufacturing and distribution of THC and CBD-infused products. Its core offering, Hourglass cream, is sold online, positioning the company within the niche of topical cannabis treatments in California's competitive landscape.

GPFT是做什么的？

Grapefruit USA, Inc., founded in 2017, is a cannabis company operating as a manufacturer and distributor of cannabis products in California. Originally named Grapefruit Boulevard Investments, Inc., the company rebranded to Grapefruit USA, Inc. in January 2020, marking a shift in its strategic focus. The company's primary product is Hourglass, a time-release THC+CBD-infused topical cream, which is sold directly to consumers through its online store. Based in Wilmington, Delaware, Grapefruit USA targets the specialty cannabis market with its unique topical application. The company's business model centers on developing and marketing cannabis-infused products that cater to specific consumer needs. While the company's operations are primarily based in California, its corporate structure is established in Delaware. Grapefruit USA aims to differentiate itself through its focus on topical cannabis solutions and direct-to-consumer sales, navigating the evolving regulatory landscape of the cannabis industry.

GPFT的投资论点是什么？

Grapefruit USA, Inc. presents a high-risk, high-reward investment profile, given its position in the volatile cannabis market. The company's focus on a single product, Hourglass cream, creates both opportunity and vulnerability. Potential the may be worth researching limited operational scale, with only 9 employees, and the negative P/E ratio of -0.90, reflecting current unprofitability. Growth hinges on expanding market reach within California and developing new products. The company's beta of -0.32 suggests a low correlation with the broader market, which may offer diversification benefits. However, the OTC listing and lack of dividend payments indicate a speculative investment.

GPFT在哪个行业运营？

Grapefruit USA, Inc. operates within the rapidly evolving cannabis industry, specifically targeting the specialty and generic drug manufacturing segment. The legal cannabis market is experiencing substantial growth, driven by increasing acceptance and legalization in various regions. However, the industry is also characterized by intense competition and regulatory complexities. Grapefruit USA's focus on topical cannabis products positions it within a niche market that may offer growth opportunities but also faces challenges from established players and changing consumer preferences. Competitors include companies like CBDL, FFNTF, HPMM, IVIXF, and JUVAF, each vying for market share in different segments of the cannabis industry.

Drug Manufacturers - Specialty & Generic

Healthcare

GPFT有哪些增长机遇？

Product Line Expansion: Grapefruit USA, Inc. can expand its product line beyond Hourglass cream to include other cannabis-infused topicals, edibles, and concentrates. The cannabis edibles market, for example, is projected to reach $5.8 billion by 2027, offering a significant growth avenue. Introducing new products can attract a broader customer base and increase revenue streams. This expansion should be carefully aligned with market demand and regulatory requirements.
Geographic Expansion within California: While currently focused on online sales, Grapefruit USA, Inc. can explore partnerships with dispensaries and retailers across California to increase its market presence. California's cannabis market is one of the largest in the United States, providing ample opportunities for growth. Establishing a physical presence can enhance brand visibility and accessibility to consumers. The timeline for this expansion depends on securing partnerships and navigating local regulations.
Strategic Partnerships: Grapefruit USA, Inc. can form strategic alliances with other companies in the cannabis industry, such as cultivators, processors, and distributors, to streamline its supply chain and reduce costs. Collaborations can also extend to research and development, enabling the company to innovate and develop new products. These partnerships can enhance Grapefruit USA's competitive advantage and accelerate its growth trajectory.
Direct-to-Consumer Marketing: Grapefruit USA, Inc. can enhance its direct-to-consumer marketing efforts through targeted online advertising, social media campaigns, and email marketing. By focusing on specific customer segments and tailoring its messaging, the company can increase brand awareness and drive sales. Investing in digital marketing infrastructure and analytics can improve the effectiveness of these campaigns. The timeline for seeing results from these efforts is typically within a few months.
Research and Development: Investing in research and development to create innovative cannabis-infused products can differentiate Grapefruit USA, Inc. from its competitors. Focusing on unique formulations, delivery methods, and therapeutic applications can attract customers seeking specialized solutions. Collaborating with research institutions and universities can provide access to cutting-edge technologies and expertise. The timeline for developing and commercializing new products can range from one to three years.

Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California.
The company's primary product is Hourglass, a time-release THC+CBD-infused topical cream.
The company sells its products directly to consumers through its online store.
Grapefruit USA, Inc. has a market capitalization of $0.00B.
The company's P/E ratio is -0.90, indicating current unprofitability.

GPFT提供哪些产品和服务？

Manufactures cannabis products
Distributes cannabis products in California
Specializes in THC+CBD-infused products
Offers Hourglass, a time-release topical cream
Sells products through its online store
Focuses on the specialty cannabis market

GPFT如何赚钱？

Develops and manufactures cannabis-infused topical creams.
Sells products directly to consumers through an online platform.
Focuses on the California cannabis market.
Generates revenue through product sales.

Consumers seeking cannabis-infused topical solutions.
Individuals looking for time-release THC+CBD products.
Customers in California interested in cannabis products.
Online shoppers interested in cannabis-related items.

Focus on a niche market (topical cannabis solutions).
Direct-to-consumer online sales channel.
Proprietary formulation of Hourglass cream.
Established brand presence in the California market.

什么因素可能推动GPFT股价上涨？

Upcoming: Potential legalization of recreational cannabis in additional states, expanding the market for Grapefruit USA's products.
Ongoing: Increasing consumer acceptance of cannabis-infused topicals for pain relief and wellness.
Upcoming: Development and launch of new cannabis-infused products beyond Hourglass cream.
Ongoing: Expansion of online marketing and sales efforts to reach a wider customer base.

GPFT的主要风险是什么？

Potential: Intense competition from established players in the cannabis industry.
Ongoing: Changing regulations and legal landscape for cannabis products.
Potential: Fluctuations in cannabis prices and demand impacting profitability.
Ongoing: Limited financial resources and operational scale compared to larger competitors.
Potential: Negative perception of cannabis products among some consumers.

GPFT的核心优势是什么？

Focus on a specific niche (topical cannabis).
Direct-to-consumer online sales.
Proprietary product formulation (Hourglass).
Established presence in the California market.

GPFT的劣势是什么？

Limited product line (primarily Hourglass cream).
Small operational scale (9 employees).
Dependence on the California market.
Negative P/E ratio indicating unprofitability.

GPFT有哪些机遇？

Expansion of product line to include other cannabis products.
Geographic expansion within California.
Strategic partnerships with other cannabis companies.
Increased direct-to-consumer marketing efforts.

GPFT面临哪些威胁？

Intense competition in the cannabis industry.
Changing regulations and legal landscape.
Fluctuations in cannabis prices and demand.
Potential for new entrants and disruptive technologies.

GPFT的竞争对手是谁？

CBD Life Sciences Inc — Focuses on CBD-based products. — (CBDL)
Fire & Flower Holdings Corp — Operates cannabis retail stores. — (FFNTF)
HPMM, Inc. — Unknown differentiation. — (HPMM)
Invictus MD Strategies Corp — Focuses on cannabis cultivation and production. — (IVIXF)
Juva Life Inc — Focuses on pharmaceutical cannabis products. — (JUVAF)

Key Metrics

MoonshotScore: 45/100

Company Profile

CEO: Bradley J. Yourist
Headquarters: Wilmington, US
Employees: 9
Founded: 2016

AI Insight

AI analysis pending for GPFT

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Grapefruit USA, Inc. do?

Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products, primarily in California. The company focuses on developing and marketing cannabis-infused topical creams, with its flagship product being Hourglass, a time-release THC+CBD cream. These products are sold directly to consumers through the company's online store, targeting individuals seeking alternative wellness solutions within the legal cannabis market.

What do analysts say about GPFT stock?

As of March 17, 2026, there is no readily available analyst coverage or consensus on Grapefruit USA, Inc. (GPFT) due to its OTC listing and small market capitalization. Investors should conduct their own independent research and due diligence, considering the company's financial performance, growth prospects, and risk factors. The lack of analyst coverage highlights the speculative nature of this investment.

What are the main risks for GPFT?

Grapefruit USA, Inc. faces several key risks, including intense competition in the cannabis industry, evolving regulations and legal uncertainties, and fluctuations in cannabis prices and demand. The company's small size and limited financial resources also pose challenges. Additionally, its reliance on a single product (Hourglass cream) increases its vulnerability to market changes and consumer preferences. Investors should carefully consider these risks before investing in GPFT.